Had a Harvard doctor, Dr. Schmamann, and he's talking about a drug, Truril. It's impossible to say these drugs, but this drug, again, he's treating patients. A doctor from Harvard, A drug, Truril... slows the progression of disease by 50, 50 to 70%. And rather than allow these patients access, the right to try it, the right to use it, the fd, for some unknown reason. (01:06–01:22)
CLAIM
Asserts that Truril slows disease progression by 50 to 70%.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
